Surgery – Controlled release therapeutic device or system
Reexamination Certificate
2008-11-10
2011-11-29
Koharski, Christopher D (Department: 3763)
Surgery
Controlled release therapeutic device or system
Reexamination Certificate
active
08066694
ABSTRACT:
A permanently implanted insulin pump or combined insulin and glucagon pumps, controlled by a valve that expands and contracts due to osmosis as a result of changes in the blood sugar level. The valve is constructed from tissues harvested or grown from the patient's body tissues to prevent rejection, infection or thrombosis. It operates the pump(s) though a blood vessel via a magnetic strip within the valve tissue and a reed switch located outside the blood vessel. The pump battery is recharged by electromagnetic induction in response to low battery warnings. Glucagon and/or insulin are refilled in response to low-level warning indicators, using self-sealing septa located near to the surface of the skin.
REFERENCES:
patent: 4538616 (1985-09-01), Rogoff
patent: 4627850 (1986-12-01), Deters et al.
patent: 5062841 (1991-11-01), Siegel
patent: 5995860 (1999-11-01), Sun et al.
patent: 6203291 (2001-03-01), Stemme et al.
patent: 6632217 (2003-10-01), Harper et al.
patent: 7011507 (2006-03-01), Seto et al.
patent: 7476224 (2009-01-01), Petrakis
patent: 2002/0123789 (2002-09-01), Francis et al.
patent: 2002/0123793 (2002-09-01), Schaldach et al.
patent: 2005/0247558 (2005-11-01), Anex et al.
patent: 2005/0261561 (2005-11-01), Jones et al.
patent: 2008/0029393 (2008-02-01), Krumme
patent: 2008/0147105 (2008-06-01), Wilson et al.
LandOfFree
Homeostatic insulin pump does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Homeostatic insulin pump, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Homeostatic insulin pump will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289806